NasdaqCM - Nasdaq Real Time Price • USD
Biodexa Pharmaceuticals Plc (BDRX)
At close: June 7 at 4:00 PM EDT
After hours: June 7 at 7:25 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2019) | Next Qtr. (Jun 2019) | Current Year (2019) | Next Year (2020) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2019) | Next Qtr. (Jun 2019) | Current Year (2019) | Next Year (2020) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 240k | 370k | -- | -- |
| Low Estimate | 240k | 370k | 1.22M | 1.22M |
| High Estimate | 240k | 370k | 1.22M | 1.22M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | ||||
|---|---|---|---|---|
| EPS Est. | -- | -- | -- | -- |
| EPS Actual | -- | -- | -- | -- |
| Difference | -- | -- | -- | -- |
| Surprise % | -- | -- | -- | -- |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2019) | Next Qtr. (Jun 2019) | Current Year (2019) | Next Year (2020) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2019) | Next Qtr. (Jun 2019) | Current Year (2019) | Next Year (2020) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 1 |
| Up Last 30 Days | -- | -- | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | BDRX | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 9.10% |
| Next Qtr. | -- | -- | -- | 11.50% |
| Current Year | -- | -- | -- | 5.70% |
| Next Year | -- | -- | -- | 12.60% |
| Next 5 Years (per annum) | -- | -- | -- | 11.34% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Initiated | Ladenburg Thalmann: Buy | 2/8/2024 |
Related Tickers
ALLR Allarity Therapeutics, Inc.
0.5010
-9.71%
NKGN NKGen Biotech, Inc.
1.4500
+5.84%
KTRA Kintara Therapeutics, Inc.
0.2103
-18.11%
SCPX Scorpius Holdings, Inc.
0.1083
-9.75%
VRAX Virax Biolabs Group Limited
1.9700
0.00%
TCBP TC Biopharm (Holdings) Plc
1.0800
-7.69%
ABIO ARCA biopharma, Inc.
3.2800
-0.91%
BPTH Bio-Path Holdings, Inc.
2.4800
-10.79%
FRES Fresh2 Group Limited
0.4375
-5.91%
GRTX Galera Therapeutics, Inc.
0.1090
-3.11%